全文获取类型
收费全文 | 1456篇 |
免费 | 183篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 28篇 |
妇产科学 | 21篇 |
基础医学 | 292篇 |
口腔科学 | 92篇 |
临床医学 | 160篇 |
内科学 | 258篇 |
皮肤病学 | 13篇 |
神经病学 | 173篇 |
特种医学 | 45篇 |
外科学 | 127篇 |
综合类 | 66篇 |
一般理论 | 7篇 |
预防医学 | 165篇 |
眼科学 | 18篇 |
药学 | 72篇 |
中国医学 | 1篇 |
肿瘤学 | 87篇 |
出版年
2021年 | 20篇 |
2020年 | 11篇 |
2019年 | 17篇 |
2018年 | 27篇 |
2017年 | 14篇 |
2016年 | 32篇 |
2015年 | 30篇 |
2014年 | 34篇 |
2013年 | 32篇 |
2012年 | 69篇 |
2011年 | 68篇 |
2010年 | 36篇 |
2009年 | 32篇 |
2008年 | 63篇 |
2007年 | 54篇 |
2006年 | 74篇 |
2005年 | 43篇 |
2004年 | 53篇 |
2003年 | 59篇 |
2002年 | 45篇 |
2001年 | 57篇 |
2000年 | 46篇 |
1999年 | 48篇 |
1998年 | 17篇 |
1997年 | 23篇 |
1996年 | 18篇 |
1995年 | 13篇 |
1994年 | 14篇 |
1993年 | 14篇 |
1992年 | 33篇 |
1991年 | 29篇 |
1990年 | 36篇 |
1989年 | 33篇 |
1988年 | 24篇 |
1987年 | 29篇 |
1986年 | 26篇 |
1985年 | 23篇 |
1984年 | 32篇 |
1983年 | 11篇 |
1982年 | 15篇 |
1981年 | 13篇 |
1979年 | 20篇 |
1978年 | 11篇 |
1976年 | 11篇 |
1974年 | 11篇 |
1973年 | 13篇 |
1972年 | 12篇 |
1967年 | 13篇 |
1966年 | 19篇 |
1965年 | 11篇 |
排序方式: 共有1640条查询结果,搜索用时 328 毫秒
41.
Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay 总被引:3,自引:0,他引:3
L H Harrison J W Ezzell T G Abshire S Kidd A F Kaufmann 《The Journal of infectious diseases》1989,160(4):706-710
An outbreak of at least 21 cases of cutaneous anthrax occurred in rural Paraguay. A case-control study revealed that disease was associated with touching the raw meat of an ill cow (odds ration = 16.5, P = .02). Serum drawn from 12 cases and 16 colony and 2 noncolony controls 6 w after the outbreak were analyzed by electrophoretic-immunotransblots (EITB) to detect serum antibodies to the protective antigen (PA) and lethal factor components of anthrax toxin. Serum was also tested by enzyme-linked immunosorbent assay (ELISA) for the presence of antibodies to poly-D-glutamic acid capsule. Of 12 cases, 11 had a positive PA screen, for a sensitivity of 91.7% (76.1%-100%, 95% confidence interval [CI]) whereas none of the 18 controls was positive for a specificity of 100% (84.8%, one-sided binomial 95% CI). Only 6 (50%) of 12 cases (21.7%-78.3%, 95% CI) had positive lethal factor titers; all controls were negative. At a cutoff of greater than or equal to 1:32 for antibodies to capsule, 11 (91.7%) of 12 (76.1%-100%, 95% CI) were positive; 16 (88.9%) of 18 controls (74.5%-100%, 95% CI) were negative. These data suggest that the EITB for detection of antibody to PA, and ELISA for detection of anticapsule antibodies are both sensitive for the retrospective diagnosis of anthrax. Both tests were specific, but EITB may be more so than ELISA. 相似文献
42.
43.
OBJECTIVESTo determine which patients with stage III endometrial cancer receiving adjuvant chemotherapy derive benefit from the addition of vaginal brachytherapy, as stage III is a highly heterogeneous population with substantial variations in practice.METHODSPatients with FIGO stage III endometrial carcinoma diagnosed 2004–2016 who underwent at least total hysterectomy and adjuvant multiagent chemotherapy were identified in the National Cancer Database. The primary outcome was overall survival according to receipt of brachytherapy, stratified by histologic type, pathological features, and status of pelvic external beam radiotherapy (EBRT), and analyzed using the Kaplan-Meier method and Cox multivariable regression.RESULTSIn total, 9369 patients were identified (24% stage IIIA, 5% stage IIIB, 71% stage IIIC; 61% endometrioid, 39% nonendometrioid histology), and 28% received brachytherapy. In the endometrioid cohort, brachytherapy was associated with a 5% absolute increase in 3-year overall survival (87% vs. 82%, p < 0.0001), which persisted in multivariable analysis (adjusted hazard ratio 0.74, 95% confidence interval 0.64–0.84, p < 0.0001). The benefit of brachytherapy was greater in patients not also receiving EBRT, and in patients with vaginal/parametrial extension, grade 3 disease, lymphovascular invasion, and/or deep myometrial invasion. In the nonendometrioid cohort, brachytherapy was associated with a significant survival benefit in univariable but not multivariable analysis, regardless of EBRT status or pathological features.CONCLUSIONSFactors predictive of brachytherapy benefit were endometrioid histology and pathological risk factors for local recurrence. Additionally, brachytherapy appeared more beneficial in patients not already receiving pelvic EBRT. Further research is warranted to determine which stage III patients may be best served by brachytherapy, EBRT, or both. 相似文献
44.
Marek Brabec Jere R Behrman Susan D. Emmett Edward Gibson Celeste Kidd William Leonard 《Annals of human biology》2013,40(4):299-313
Background: Seasons affect many social, economic, and biological outcomes, particularly in low-resource settings, and some studies suggest that birth season affects child growth.Aim: To study a predictor of stunting that has received limited attention: birth season.Subjects and methods: This study uses cross-sectional data collected during 2008 in a low-resource society of horticulturists-foragers in the Bolivian Amazon, Tsimane’. It estimates the associations between birth months and height-for-age Z-scores (HAZ) for 562 girls and 546 boys separately, from birth until age 11?years or pre-puberty, which in this society occurs ~13–14?years.Results: Children born during the rainy season (February–May) were shorter, while children born during the end of the dry season and the start of the rainy season (August–November) were taller, both compared with their age–sex peers born during the rest of the year. The correlations of birth season with HAZ were stronger for boys than for girls. Controlling for birth season, there is some evidence of eventual partial catch-up growth, with the HAZ of girls or boys worsening until?~?age 4–5?years, but improving thereafter. By age 6?years, many girls and boys had ceased to be stunted, irrespective of birth season.Conclusion: The results suggest that redressing stunting will require attention to conditions in utero, infancy and late childhood. 相似文献
45.
46.
Tsutsumi YM Horikawa YT Jennings MM Kidd MW Niesman IR Yokoyama U Head BP Hagiwara Y Ishikawa Y Miyanohara A Patel PM Insel PA Patel HH Roth DM 《Circulation》2008,118(19):1979-1988
47.
Lydia Poole Elizabeth Leigh Tara Kidd Amy Ronaldson Marjan Jahangiri Andrew Steptoe 《Journal of psychosomatic research》2014
Objective
To understand the association between pre-operative depression symptoms, including cognitive and somatic symptom subtypes, and length of post-operative stay in patients undergoing coronary artery bypass graft (CABG) surgery, and the role of socioeconomic status (SES).Methods
We measured depression symptoms using the Beck Depression Inventory (BDI) and household income in the month prior to surgery in 310 participants undergoing elective, first-time, CABG. Participants were followed-up post-operatively to assess the length of their hospital stay.Results
We showed that greater pre-operative depression symptoms on the BDI were associated with a longer hospital stay (hazard ratio = 0.978, 95% CI 0.957–0.999, p = .043) even after controlling for covariates, with the effect being observed for cognitive symptoms of depression but not somatic symptoms. Lower SES augmented the negative effect of depression on length of stay.Conclusions
Depression symptoms interact with socioeconomic position to affect recovery following cardiac surgery and further work is needed in order to understand the pathways of this association. 相似文献48.
L.R. Kidd D.Q. Nguyen S.C. Lyons W.A. Dickson 《Burns : journal of the International Society for Burn Injuries》2013
Paediatric burn follow-up optimally follows a balance between complication detection and avoiding unnecessary hospital visits. In a long-term review, we assessed complication patterns in children with burns requiring surgery. Using the Welsh Burns Centre database, a retrospective note review of paediatric burns over 3 years from 1995 was performed, identifying all children undergoing surgery for their burns. 94 patients were identified with a median follow-up since injury of 13.6 years. Mean age was 5.27 (SD = 4.9) years. TBSA ranged from <1 to 70%. 94% underwent split-skin grafting. 18% (n = 17) developed contractures and 33% (n = 31) developed hypertrophic scarring. Those developing contractures were younger, and suffered significantly greater TBSA burns (p < 0.05) than those developing hypertrophic scarring or those without complications. All contractures developed within 1–13 months, and hypertrophic scarring within 1–17 months. All patients sustaining axillary burns developed contractures, whilst 75% of contractures developed around the upper limb. 相似文献
49.
Pre‐transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post‐kidney transplantation
下载免费PDF全文
![点击此处可从《Clinical transplantation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Gaurav Gupta Hasan Fattah Rivka Ayalon Jason Kidd Todd Gehr Luis F. Quintana Pamela Kimball Salima Sadruddin H. Davis Massey Dhiren Kumar Anne L. King Laurence H. Beck Jr 《Clinical transplantation》2016,30(4):461-469
Previous studies that have assessed the association of pre‐transplant antiphospholipase A2 receptor autoantibody (PLA2R‐Ab) concentration with a recurrence of membranous nephropathy (rMN) post‐kidney transplant have yielded variable results. We tested 16 consecutive transplant patients with a history of iMN for pre‐transplant PLA2R‐Ab. Enzyme‐linked immunosorbent assay titers (Euroimmun, NJ, USA) >14 RU/mL were considered positive. A receiver operating characteristic (ROC) analysis was performed after combining data from Quintana et al. (n = 21; Transplantation February 2015) to determine a PLA2R‐Ab concentration which could predict rMN. Six of 16 (37%) patients had biopsy‐proven rMN at a median of 3.2 yr post‐transplant. Of these, five of six (83%) had a positive PLA2R‐Ab pre‐transplant with a median of 82 RU/mL (range = 31–1500). The only patient who had rMN with negative PLA2R‐Ab was later diagnosed with B‐cell lymphoma. One hundred percent (n = 10) of patients with no evidence of rMN (median follow‐up = five yr) had negative pre‐transplant PLA2R‐Ab. In a combined ROC analysis (n = 37), a pre‐transplant PLA2R‐Ab > 29 RU/mL predicted rMN with a sensitivity of 85% and a specificity of 92%. Pre‐transplant PLA2R‐Ab could be a useful tool for the prediction of rMN. Patients with rMN in the absence of PLA2R‐Ab should be screened for occult malignancy and/or alternate antigens. 相似文献